Metraipolis › archive › dc_bf44ba0eb76e

Platinum-based therapeutics as emerging multi-modal radiosensitizers in glioblastoma treatment — Europe PMC PMID:41692149

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41692149
DOI
10.1016/j.addr.2026.115811
License (as archived)
solo-consultazione
Archived
2026-11-05T20:58:36.069Z
SHA-256 of the archived text
39d53444961046ce23d449e48c7af8c424255498025a7f906da87b7b5fa5bf88
Stable URL of this page
https://metraipolis.com/documento/dc_bf44ba0eb76e

How to cite

Platinum-based therapeutics as emerging multi-modal radiosensitizers in glioblastoma treatment — Europe PMC PMID:41692149 — Europe PMC (en), https://europepmc.org/article/MED/41692149 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bf44ba0eb76e (Metraipolis archive dc_bf44ba0eb76e, sha256 39d53444961046ce23d449e48c7af8c424255498025a7f906da87b7b5fa5bf88)
BibTeX
@misc{dcbf44ba0eb76e,
  title = {Platinum-based therapeutics as emerging multi-modal radiosensitizers in glioblastoma treatment — Europe PMC PMID:41692149},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41692149},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bf44ba0eb76e; sha256 39d53444961046ce23d449e48c7af8c424255498025a7f906da87b7b5fa5bf88},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41692149. Agents can read the archived copy with the MCP tool read_document.